Publications by authors named "Sherry A Goodner"

Claim this Profile
A
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors.
Paula M Fracasso, George A Fisher, Sherry A Goodner, Jan H Beumer, Merrill J Egorin

Am J Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer.
Paula M Fracasso, Linda R Duska, Premal H Thaker, Feng Gao, Imran Zoberi, Sherry A Goodner

Am J Clin Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies.
Paula M Fracasso, Sherry A Goodner, Jonathan D Wildi, Michael J Naughton, Gerald P Linette

Am J Clin Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coaching intervention as a strategy for minority recruitment to cancer clinical trials.
Paula M Fracasso, Sherry A Goodner, Allison N Creekmore, Helen P Morgan, Denise M Foster

J Oncol Pract· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
Paula M Fracasso, Kerry J Williams, Ronald C Chen, Joel Picus, Cynthia X Ma, Sherry A Goodner

Cancer Chemother Pharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignancies.
Paula M Fracasso, Joel Picus, Jonathan D Wildi, Sherry A Goodner, Allison N Creekmore

Cancer Chemother Pharmacol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab: pharmacokinetic and pharmacodynamic rationale for dosing.
Paula M Fracasso, Howard Burris, Matthew A Arquette, Ramaswamy Govindan, Feng Gao, Sherry A Goodner

Clin Cancer Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.
Ramaswamy Govindan, Wan-Teck Lim, Matthew A Arquette, Sherry A Goodner, Carole L Fears

Oncol Rep· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.
Paula M Fracasso, Lori J Goldstein, Dinesh P de Alwis, Janet S Rader, Matthew A Arquette, Sherry A Goodner

Clin Cancer Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.
Paula M Fracasso, Luis C Rodriguez, Thomas J Herzog, Carole L Fears, Sherry A Goodner

Cancer· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis